Physician profile
Max W Cohen
NPI 1467446039
$5,208.82
in general payments reported to CMS, 2019-2025
19 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,056 · 2020: $606 · 2021: $285 · 2022: $534 · 2023: $319 · 2024: $2,289 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,998 · Food and Beverage: $708 · Education: $21.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,998.12 |
| Food and Beverage | $708.21 |
| Education | $21.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $993.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $823.79 | 2019-2020 | |
| Providence Medical Technology, INC. | $676.20 | 2019-2022 | |
| Piedmont Plus Innovation | $626.68 | 2024 | |
| Arthrex, INC. | $578.25 | 2024 | |
| Medtronic, INC. | $424.75 | 2021-2023 | Pivox Oblique Lateral Spinal System, Anatomic Peek Ptc Cervical Fusion System, Catalyft Pl Expandable Interbody System |
| Boston Scientific Corporation | $338.70 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $309.04 | 2019-2024 | Senza |
| Intrinsic Therapeutics | $93.68 | 2025 | Barricaid Acd (Annular Closure Device) |
| Abbott Laboratories | $90.92 | 2022-2025 | Eterna, Proclaim |
| Orthofix Medical, INC. | $77.73 | 2019-2024 | Spinal-Stim, Spinal-Stim |
| Electronic Waveform Lab, INC. | $52.56 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $25.69 | 2021 | |
| Radius Health, INC. | $20.86 | 2019 | |
| Si-Bone, INC. | $18.67 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $16.77 | 2021 | |
| Shionogi INC | $15.02 | 2019 | |
| Pfizer INC. | $14.72 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.